NAFDAC Approves ABUAD Herbal Drug For COVID-19

Written by on January 5, 2022

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved a herbal drug that was produced by Afe Babalola University, Ado-Ekiti (ABUAD) for the treatment of COVID-19.

The founder of the University, also a senior advocate of Nigeria, Chief Afe Babalola disclosed this yesterday, in Ado-Ekiti, Ekiti State, at a ceremony commemorating the 12th anniversary of the establishment of ABUAD.

According to him, the drug had been tested on 19 COVID-19 patients and all recovered.

He said the number of those cured by the drug had been on the increase since the drug was approved.

He said the research department of the university over the years had made meaningful discoveries aimed at solving the socio-economic problems of the country.

He said: “I am happy that I conceived this university 12 years ago and since then, we have been going from strength to strength, making exploits in all our endeavors. Our vision is to make this place a great institution in the university education in the country in teaching, research and community service.

“I can confirm to you today that our herbal drug produced through extensive research by our team of researchers has healed about 19 patients who contracted covid-19 pandemic. They were healed perfectly less than five days of usage, which tells you the level of our research in ABUAD.”



Reader's opinions

Leave a Reply

Your email address will not be published. Required fields are marked *

Current track